Renin inhibitors for the prevention and treatment of hypertension in obese patients

Details for Australian Patent Application No. 2007333095 (hide)

Owner Novartis AG

Inventors Prescott, Margaret Forney

Agent Davies Collison Cave

Pub. Number AU-B-2007333095

PCT Pub. Number WO2008/074001

Priority 60/870,180 15.12.06 US

Filing date 13 December 2007

Wipo publication date 19 June 2008

Acceptance publication date 24 March 2011

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/074001 Priority application(s): WO2008/074001

24 March 2011 Application Accepted

  Published as AU-B-2007333095

21 July 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007333097-Hair styling composition

2007333080-Improved downhole scraping and/or brushing tool and related methods